Continued Fallout from Macchiarini Misconduct

The sacked researcher and surgeon was not properly vetted by the Swedish institutions that hired him in 2010, according to an independent review panel.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, DEBORABALVESThe swath of destruction caused by the alleged misconduct and fraud of surgeon Paolo Macchiarini continues to widen, as an independent panel reviews his case. In a report released last week (August 31), investigators commissioned by the Karolinska University Hospital—where Macchiarini used to work—stated that both the hospital and the Karolinska Institute (KI) failed to heed warning signs that the artificial organ researcher’s skill and professionalism was not up to par with the reputation he had cultivated in the popular press.

“Macchiarini was recruited as a senior physician at the hospital even though there were strongly critical opinions from his previous employers,” the investigators wrote. “Group thinking, bandwagon effects, a very competitive care environment, many informal leaders and deficient knowledge of and respect for rules are some of the factors that may have contributed to the course of events.”

Two KI officials are suffering backlash from the Macchiarini case. Anders Hamsten, who had already resigned from the institute’s vice-chancellor position over his role in hiring Macchiarini, and Harriet Wallberg, who was president of KI when the surgeon was hired, were both dismissed from the panel that awards Nobel Prizes for Medicine, according to The Guardian. In addition, Wallberg was fired from her post as the chancellor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo